Biodesix News

Biodesix to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting

Data highlights ability of the Nodify XL2 test to identify benign nodules in patients with emphysema.

Business WireMay 21 06:00 ET

Biodesix Initiated at Buy by TD Cowen

Biodesix Initiated at Buy by TD Cowen

Dow JonesMay 13 07:36 ET

Biodesix Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/13/2024 68.67% TD Cowen → $2.8 Initiates Coverage On → Buy 05/03/2024 80.72% Lake Street → $3 Initiates

BenzingaMay 13 07:25 ET

Buy Rating Justified by Biodesix's Market Leadership and Strong Growth Prospects

TipRanksMay 13 05:45 ET

Express News | Biodesix Inc : TD Cowen Initiates With Buy Rating; Price Target $2.8

ReutersMay 13 05:39 ET

Biodesix(BDSX.US) Officer Sells US$642.1 in Common Stock

$Biodesix(BDSX.US)$ Officer Pestano Gary Anthony sold 434 shares of common stock on May 9, 2024 at an average price of $1.4795 for a total value of $642.1.Source: Announcement What is statement of cha

moomoo NewsMay 10 17:49 ET

Biodesix(BDSX.US) Officer Sells US$361 in Common Stock

$Biodesix(BDSX.US)$ Officer Vazquez Chris sold 244 shares of common stock on May 9, 2024 at an average price of $1.4795 for a total value of $361.Source: Announcement What is statement of changes in b

moomoo NewsMay 10 17:48 ET

Biodesix(BDSX.US) Officer Sells US$692.41 in Common Stock

$Biodesix(BDSX.US)$ Officer O'Kane Kieran sold 468 shares of common stock on May 9, 2024 at an average price of $1.4795 for a total value of $692.41.Source: Announcement What is statement of changes i

moomoo NewsMay 10 17:48 ET

Biodesix(BDSX.US) Officer Sells US$5,568.84 in Common Stock

$Biodesix(BDSX.US)$ Officer Hutton Scott sold 3,764 shares of common stock on May 9, 2024 at an average price of $1.4795 for a total value of $5,568.84.Source: Announcement What is statement of change

moomoo NewsMay 10 17:48 ET

Biodesix(BDSX.US) Officer Sells US$1,449.91 in Common Stock

$Biodesix(BDSX.US)$ Officer Cowie Robin Harper sold 980 shares of common stock on May 9, 2024 at an average price of $1.4795 for a total value of $1,449.91.Source: Announcement What is statement of ch

moomoo NewsMay 10 17:47 ET

Biodesix Inc (BDSX) Surpasses Analyst Revenue Forecasts With Strong Q1 2024 Performance

Yahoo FinanceMay 10 15:55 ET

Earnings Call Summary | Biodesix(BDSX.US) Q1 2024 Earnings Conference

The following is a summary of the Biodesix, Inc. (BDSX) Q1 2024 Earnings Call Transcript:Financial Performance:Biodesix reported a Q1 revenue of $14.8 million, a notable increase of 64% over the prior

moomoo AIMay 10 08:21 ET · Conference Call

Biodesix, Inc. (BDSX) Q1 2024 Earnings Call Transcript

Biodesix, Inc. (BDSX) Q1 2024 Earnings Call Transcript

Earnings Call TranscriptsMay 10 01:06 ET

Analysts Offer Insights on Healthcare Companies: GoodRx Holdings (GDRX), Petiq (PETQ) and Biodesix (BDSX)

TipRanksMay 9 09:00 ET

Buy Rating Affirmed for Biodesix on Robust Q1 Performance and Market Position Strength

TipRanksMay 9 07:06 ET

Biodesix Inc (BDSX) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...

Yahoo FinanceMay 9 03:46 ET

Express News | Biodesix Reaffirms 2024 Revenue Guidance $65M-$68M

BenzingaMay 8 17:06 ET

Express News | Biodesix Inc - Reaffirms 2024 Financial Outlook and Expects to Generate Between $65 Mln and $68 Mln in Total Revenue in 2024

ReutersMay 8 16:20 ET

Biodesix | 10-Q: Quarterly report

Futu NewsMay 8 16:19 ET · Announcements

Biodesix Q1 2024 GAAP EPS $(0.14), Inline, Sales $14.818M Beat $14.180M Estimate

Biodesix (NASDAQ:BDSX) reported quarterly losses of $(0.14) per share which met the analyst consensus estimate. This is a 41.67 percent increase over losses of $(0.24) per share from the same period l

BenzingaMay 8 16:08 ET